Update on sedative hypnotics.
D014151:Anti-Anxiety Agents / Q000009:adverse effects; D001463:Barbiturates / Q000627:therapeutic use; D001569:Benzodiazepines; D004348:Drug Labeling; D004363:Drug Utilization; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy; D014481:United States; D014486:United States Food and Drug Administration
D014151:Anti-Anxiety Agents; D001463:Barbiturates; D006993:Hypnotics and Sedatives; D001569:Benzodiazepines